Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN Study

18 Aug 2025

Abstract excerpt

OBJECTIVES: Neuroblastoma is the most common extracranial solid tumor in infants, with a possibility of spontaneous regression even in disseminated disease. Despite an overall good prognosis, relapse can worsen the outcome for some patients. A long-term analysis is crucial to identify subgroups of patients with poorer prognosis, assessing the risks of late relapse, progression or long-term toxicity associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Glioma Diagnosis and Treatment
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40827024
DOI: 10.1002/pbc.31982

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN StudyPMID 40827024Read ↗

Neuroblastoma in Infants: Long Term Survival from INES Protocols - A SIOPEN StudySemantic proximity Read ↗

Neuroblastoma: biological insights into a clinical enigma.Semantic proximity Read ↗

Survival of high‐risk pediatric neuroblastoma patients in a developing countrySemantic proximity Read ↗

Neuroblastoma: biology, prognosis, and treatment.Semantic proximity Read ↗

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children’s Oncology Group Study ANBL0531Semantic proximity Read ↗

Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Semantic proximity Read ↗

Neuroblastoma: a clinical challenge and biologic puzzleSemantic proximity Read ↗

Neuroblastoma—A Neural Crest Derived Embryonal MalignancySemantic proximity Read ↗

MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4SSemantic proximity Read ↗

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.Semantic proximity Read ↗

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)Semantic proximity Read ↗

Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committeeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.